Rigel
corporate overview

pipeline

investors & media

careers



 press release archive


Current | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997


11/4/2002 Rigel Announces Third Quarter Financial Results
11/1/2002 Rigel Ligase Research Featured at AACR Symposium
10/30/2002 Rigel Pharmaceuticals Appoints Susan Scher, M.D., to New Post of V.P., Strategic Relations
10/29/2002 Rigel to Present at CIBC World Markets Health Care Conference on November 4
10/7/2002 Rigel Reports Progress in Drug Development Programs
10/1/2002 Rigel To Present At UBS Warburg’s Global Life Sciences Conference On October 7, 2002
9/18/2002 Rigel Moves First Drug into Clinical Testing
8/12/2002 Rigel and Daiichi Sign Agreement in New Field of Cancer Drug Discovery
8/6/2002 Rigel Announces Second Quarter 2002 Financial Results
7/9/2002 Rigel to Present Update on Hepatitis C Drug Development Program
6/24/2002 Rigel and Inoxell Enter Global Patent Settlement Agreement
5/16/2002 Libraria Partners with Rigel to Turn Genomic Targets into Drugs
5/7/2002 Rigel Announces First Quarter 2002 Financial Results
5/6/2002 Rigel Delivers Additional Respiratory Drug Research Targets and Completes Discovery Phase of Target Identification Collaboration with Pfizer
4/9/2002 Rigel Announces Data on Its Multiple Cancer Therapy Targets at AACR Meeting
4/2/2002 Rigel Pharmaceuticals Appoints Elliott Grossbard, M.D., Senior Vice President Of Medical Development
2/26/2002 Rigel Pharmaceuticals to Present at Lehman Brothers Healthcare Conference
2/25/2002 Brian Cunningham Named Chairman of Bay Area Bioscience Center
2/21/2002 Rigel Acquires Technology From Leading Research Institutions to Advance Genomic Target Discovery Programs
2/19/2002 Rigel To Present at BIO CEO & Investor Conference 2002
2/5/2002 Rigel Announces Fourth Quarter and Year End 2001 Financial Results
1/31/2002 Rigel Collaboration with Johnson & Johnson Pharmaceutical Research & Development Yields Validated Targets for Cancer Drug Development
1/17/2002 Rigel Announces $31.5 Million Offering of Common Stock
1/7/2002 Rigel Announces That Johnson & Johnson Pharmaceutical Research & Development Extends Collaboration To Discover New Cancer Therapeutics And Diagnostics
© 2010 Rigel  |  privacy  |  disclaimer | Follow Us On:    contact us  |  site map  |  search    Search